171 related articles for article (PubMed ID: 7529247)
1. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
[TBL] [Abstract][Full Text] [Related]
2. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
[TBL] [Abstract][Full Text] [Related]
5. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
Engel PM; Dennin RH
Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.
Chaudhary RK; MacLean C
J Clin Microbiol; 1991 Oct; 29(10):2329-30. PubMed ID: 1719025
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
[TBL] [Abstract][Full Text] [Related]
9. Detection of hepatitis C virus infection with recombinant immunoblot assay, synthetic immunoblot assay, and polymerase chain reaction.
Chaudhary RK; Andonov A; MacLean C
J Clin Lab Anal; 1993; 7(3):164-7. PubMed ID: 7685380
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
Marcellin P; Martinot-Peignoux M; Elias A; Branger M; Courtois F; Level R; Erlinger S; Benhamou JP
J Infect Dis; 1994 Aug; 170(2):433-5. PubMed ID: 7518489
[TBL] [Abstract][Full Text] [Related]
11. Serological diagnosis of hepatitis C virus in patients with liver disease in Saudi Arabia. Evaluation of antibody determination by recombinant immunoblot assays in relation to RNA detection by polymerase chain reaction.
Al-Ahdal MN; Kessie G
Diagn Microbiol Infect Dis; 1997 Mar; 27(3):69-73. PubMed ID: 9147007
[TBL] [Abstract][Full Text] [Related]
12. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
[TBL] [Abstract][Full Text] [Related]
14. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay.
Buffet C; Charnaux N; Laurent-Puig P; Chopineau S; Quichon JP; Briantais MJ; Dussaix E
J Med Virol; 1994 Jul; 43(3):259-61. PubMed ID: 7523581
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of indeterminate sera for hepatitis C virus by assays using synthetic peptides.
Rivanera D; Lorino G; Lilli D; Dicuonzo G; Mancini C
Eur J Epidemiol; 1994 Apr; 10(2):235-7. PubMed ID: 7529196
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
17. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
18. Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay.
Suslov AP; Kuzin SN; Golosova TV; Shalunova NV; Malyshev NA; Sadikova NV; Vavilova LM; Somova AV; Musina EE; Ivanova MV; Kipor TT; Timonin IM; Kuzina LE; Godkov MA; Bajenov AI; Nesterenko VG
Russ J Immunol; 2002 Jul; 7(2):175-84. PubMed ID: 12687261
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of biochemical, hematological, RIBA and PCR assays in predicting viremia in anti-HCV positive patients.
Sirin MC; Cicioglu Aridogan B; Sesli Cetin E; Sirin FB
J Infect Dev Ctries; 2019 Aug; 13(8):736-743. PubMed ID: 32069258
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between different hepatitis C virus screening and confirmatory assays.
Berger A; Doerr HW; Preiser W; Weber B
J Virol Methods; 1996 May; 59(1-2):141-6. PubMed ID: 8793841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
